Home LiteratureArticle Details
PMID: 10072481 Published · ppublish English

Cutting edge: a role for the adaptor protein LAT in human NK cell-mediated cytotoxicity.

Journal of immunology (Baltimore, Md. : 1950) ·Vol. 162 ·No. 5 ·1999-04-14

Jevremovic D, Billadeau D D, Schoon R A, Dick C J, Irvin B J, Zhang W, Samelson L E, Abraham R T, Leibson P J

Abstract

Stimulation of NK cell-mediated cytotoxicity involves the coupling of proximal Src and Syk family protein tyrosine kinases to downstream effectors. However, the mechanisms linking these second messenger pathways are incompletely understood. Here, we describe a key role for the LAT (p36) adaptor protein in human NK cell activation. LAT is tyrosine phosphorylated upon stimulation of NK cells through FcgammaRIII receptors and following direct contact with NK-sensitive target cells. This NK stimulation induces the association of LAT with several phosphotyrosine-containing proteins. In addition to the biochemical evidence showing LAT involvement in NK cell activation, a genetic model shows that LAT is required for FcR-dependent phosphorylation of phospholipase C-gamma. Furthermore, overexpression of LAT in NK cells leads to increased Ab-dependent cell-mediated cytotoxicity and "natural cytotoxicity," thus demonstrating a functional role for LAT in NK cells. These data suggest that LAT is an important adaptor protein for the regulation of human NK cell-mediated cytotoxicity.

Article Info
Journal
Journal of immunology (Baltimore, Md. : 1950)
Abbr.
J Immunol
Published
1999-04-14
Indexed
1999-04-14
Updated
2007-11-15
Language
English
Country/Region
United States
NLM ID
2985117R
Analysis Services
Analysis Services

Contact

No. 2 Wenbo Road, Zhangqiu District, Jinan, Shandong

Qilu Normal University · Genelibs Bioinformatics Lab

750 Shunhua Rd, Jinan

2F, Bldg F, University Science Park

Tel: 0531-88819269

WeChat Official Account

Follow our WeChat subscription account for real-time updates and the latest in medical and biological research.


Business Email

E-mail: [email protected]